What is Monte Rosa Therapeutics, Inc.'s total revenue?

Monte Rosa Therapeutics, Inc. (GLUE) reported total revenue of $4.21M in Q1 2026.

How has Monte Rosa Therapeutics, Inc.'s total revenue changed year-over-year?

Monte Rosa Therapeutics, Inc.'s total revenue decreased by 95.0% year-over-year, from $84.93M to $4.21M.

What does total revenue mean?

The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.

Monte Rosa Therapeutics, Inc. GLUE Total Revenue

Total Revenue at other companies

Bristol-Myers SquibbBMY

$11.49B+2.6%

Nurix Therapeutics, Inc.NRIX

$6.25M-66.1%

Kymera TherapeuticsKYMR

$34.37M+55.5%

ImmunomeIMNM

$0-100%

Adaptive BiotechnologiesADPT

$70.87M+35.1%

Arcus BiosciencesRCUS

$17M-39.3%

Other financials

Income statement

See full

Operating income-$50.0M-214%

Net income-$44.5M-195%

EPS (diluted)-$0.45-179%

Balance sheet

See full

Cash & equivalents$159.9M+104%

Total debt$39.1M-6.7%

Total equity$521.9M+89.7%

Total assets$736.4M+87.3%

Cash flow

See full

Operating cash flow-$37.4M+17.9%

CapEx$1.9M+17.7%

Free cash flow-$39.2M+16.7%

Valuation

See full

Market cap$1.75B+361%

Enterprise value$1.63B+381%

P/S40.7×+38.4×

Profitability

See full

Operating margin-345.2%—

Net margin-302.6%—

FCF margin-45.8%-64.9pp

Returns & leverage

See full

Return on equity-32.6%—

Debt / equity0.1×-0.1×

Current ratio9.5×+3.9×

Where this comes from

Reported directly by Monte Rosa Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The official record: Monte Rosa Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Monte Rosa Therapeutics, Inc.'s total revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Monte Rosa Therapeutics, Inc.'s total revenue?: Monte Rosa Therapeutics, Inc. (GLUE) reported total revenue of $4.21M in Q1 2026.
How has Monte Rosa Therapeutics, Inc.'s total revenue changed year-over-year?: Monte Rosa Therapeutics, Inc.'s total revenue decreased by 95.0% year-over-year, from $84.93M to $4.21M.
What does total revenue mean?: The aggregate of all revenue from the company's operations — the top line from which all profitability metrics are derived.